ORBi: Detailled Reference

Article (Scientific journals)

What's New in Renal and Pancreatic Transplantation in 2011?

WEEKERS, Laurent

2012 • In Transplantation Proceedings, 44 (9), p. 2784–2786

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/156744

DOI
10.1016/j.transproceed.2012.09.093

PubMed
23146524

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

1-s2.0-S0041134512010755-main.pdf

Publisher postprint (99.68 kB)

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

kidney transplantation; pancreas transplantation

Abstract :

[en] At the 11th meeting of the SFT Congress in Montpellier, several presentations were devoted to humoral rejection of kidney transplants, new immunosuppressive drugs, cancer after transplantation, and second pancreas transplantations. The main information drawn from these papers is summarized in this brief review.

Disciplines :

Urology & nephrology

Author, co-author :

WEEKERS, Laurent ; Centre Hospitalier Universitaire de Liège - CHU > Néphrologie

Language :

English

Title :

What's New in Renal and Pancreatic Transplantation in 2011?

Publication date :

November 2012

Journal title :

Transplantation Proceedings

ISSN :

0041-1345

eISSN :

1873-2623

Publisher :

Elsevier Science, New York, United States - New York

Volume :

44

Issue :

9

Pages :

2784–2786

Peer reviewed :

Peer Reviewed verified by ORBi

Funders :

SFT

Available on ORBi :

since 06 October 2013

Statistics

Number of views

95 (2 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics

Scopus citations^®

0

Scopus citations^®
without self-citations

0

OpenCitations

0

Bibliography

Sis, B., Jhangri, G.S., Bunnag, S., Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining (2009) Am J Transplant, 9, p. 2312
Loupy, A., Hill, G.S., Suberbielle, C., Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with performed donor-specific antibodies (DSA) (2011) Am J Transplant, 11, p. 56
Bachelet, T., Guidicelli, G., Couzi, L., Corrélation entre DSA caractérisés en identification single AntigenBeads LUMINEX et résultats de crossmatch XIe Congrès Annuel de la Société Francophone de Transplantation 2011, pp. O11. , Montpellier
Del Belo, A., Congy, N., Sallusto, F., Apparition d'anticorps anti-HLA dirigés contre le greffon après arrêt de I'immunosuppression avec ou sans transplantectomie XIe Congrès Annuel de la Société Francophone de Transplantation 2011, pp. O13. , Montpellier
Rifle, G., Mousson, C., Martin, L., Donor-specific antibodies in allograft rejection: Clinical and experimental data (2005) Transplantation, 79 (SUPPL. 3), p. 14
Snanoudj, R., Candon, S., Legendre, C., Lymphocytes B mémoire et synthèse des anticorps anti-HLA chez des patients immunisés en pré-transplantation XIe Congrès Annuel de la Société Francophone de Transplantation 2011, pp. O14. , Montpellier
Vincenti, F., Larsen, C.P., Alberu, J., Résultata à 3 ans de l'étude BENEFIT: étude de phase III belatacept versus cyclosporine chez les patients transplantés rénaux XIe Congrès Annuel de la Société Francophone de Transplantation 2011, pp. O50. , Montpellier
Pestana, J.M., Grinyo, J., Vanrenterghem, Y., Belatacept versus cyclosporine chez les patients ranspalntés d'un donneur à critères élargis: résultas à 3 ans de l'étude de phase III BENEFIT-EXT XIe Congrès Annuel de la Société Francophone de Transplantation 2011, p. 048. , Montpellier
Stegall, M.D., Diwan, T., Raghavaiah, S., Terminal complement inhibition decreases antibodymediated rejection in sensitized renal transplant recipients (2011) Am J Transplant, 11, p. 2405
Euvrard, S., Morelon, E., Rostaing, R., Efficacité de la rapamycine dans la prévention secondaire des cancers cutanés chez les transplantés rénaux. Résultats à 2 ans XIe Congrés Annuel de la Société Francophone de Transplantation 2011, p. 049. , Montpellier
Salgo, R., Gossmann, J., Schöffer, H., Switch to a sirolimus-based immunosuppression in longterm renal transplant recipients: Reduced rate of (pre-)malignancies and nonmelanoma skin cancer in a prospective, randomized, assessor-blinded, controlled clinical trial (2010) Am J Transplant, 10, p. 1385
Harden, P., Reduced rate of cutaneous squamous cell skin carcinoma in randomised, prospective, multi-centre controlled trial of conversion to sirolimusbased immunosuppresiion: The RESCUE trial 15th Congres of the European Society of Organ Transpantation 2011: Glasgow, , LB-O-006
Alberu, J., Pascoe, M.D., Campistol, J.M., Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-month results from the CONVERT trial (2011) Transplantation, 92, p. 303
Buron, F., Thaunat, O., Demuylder-Mischler, S., Retransplantation pancréatique: une deuxième chance pour les patients diabétiques? XIe Congrès Annuel de la Société Francophone de Transplantation 2011, p. 055. , Montpellier

Similar publications